Case Studies in Managing Hepatitis Co-Infection
in Those with HIV: Clinical Pearls – A STEP-HIV Initiative
Release Date: October 22, 2019
Expiration Date: October 22, 2020
Estimated Time to Complete: 1.0 hours
No Longer Available for Credit
Jointly Provided by
Support for this activity has been made possible through
educational grants from Gilead Sciences and ViiV Healthcare.
We are pleased to invite you to participate in the latest activity in a series of Special Training for Effective Providers in HIV (STEP-HIV) initiatives to promote HIV workforce development.
This CME/CNE-Certified web activity focuses on Hepatitis C, which remains a leading cause of liver-related mortality in people living with HIV infection (PLWH). Through a series of cases, this session will provide members of the care team with practical knowledge they can apply to patient care regarding how to manage and counsel those with HIV/HCV coinfection, and offer clinical pearls specific to direct-acting antiviral therapy and liver cancer screening in this key population.
- How to evaluate and counsel a person with HIV/HCV coinfection
- How to identify clinical factors that influence choice of HCV treatment
- When to incorporate liver cancer screening
After participating in the activity, learners should be better able to:
- Evaluate and counsel a patient with HIV/HCV coinfection;
- Identify the clinical factors involved in the choice of hepatitis C treatment in people living with HIV; and
- Describe the importance of incorporating liver cancer screening in selected patients with hepatitis C infection.
Nina Kim, MD, MSc
Associate Professor of Medicine
University of Washington
Dr. Nina Kim is an Associate Professor of Medicine in the Division of Allergy & Infectious Diseases at the University of Washington (UW). She is the Director of the Madison HIV/Hepatitis Coinfection Clinic and one of the core clinicians at the Liver Clinic at Harborview Medical Center. She received her medical degree at University of California San Francisco, completed her training in internal medicine and infectious disease at the UW and later received a master’s of science in epidemiology at the UW School of Public Health. She serves as the Director of the Translational Research sub-core of the UW/Fred Hutch Center for AIDS Research and is the Associate Editor of Hepatitis C Online, a CDC-sponsored web-based curriculum.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and ACTHIV. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours (0.4 Pharmacotherapeutic Contact Hours).
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until October 22, 2020. PAs should only claim credit commensurate with the extent of their participation.
Other Members of the Healthcare Team
The American Academy of CME, Inc. will provide a certificate of participation to all other members of the HIV care team.
This activity has been designed to meet the educational needs of the HIV care team, including physicians (both specialists and primary care/family medicine), nurses, nurse practitioners, physician assistants, and pharmacists who are in practice but are newer to HIV medicine or who are in training. Other healthcare providers may also participate.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
Nina Kim, MD, MSc: No relevant financial relationships with any commercial interests.
Sharon Lee, MD, Medical Director, Southwest Boulevard Family Health Care Services of Greater Kansas City, (Kansas); President, ACTHIV: No relevant financial relationships with any commercial interests.
John JD Juchniewicz, MCIS, CHCP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME, Inc.: No relevant financial relationships with any commercial interests.
This activity may contain discussion of off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, ACTHIV or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
This activity will discuss off-label information.
Privacy and Contact
© 2019. This CME/CE-certified activity is held as copyrighted © by American Academy of CME and ACTHIV. Through this notice, the Academy and ACTHIV grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).